How to Use Non-Human Primate NASH Model for New Drug Evaluation?

Time: 11:30 am
day: Day 1 Stream 2 AM

Details:

  • Discussing the recent progress of KBI’s unique NHP NASH/fibrosis model in close association with metabolic dysregulations
  • Exploring non-invasive imaging technologies for NASH and for improving detection of early stages of liver fibrosis
  • Characteristics of syndrome associated NASH in cynomolgus monkeys based on clinical criteria
  • Translational research for the evaluation of efficacy and safety the monkey model of NASH
  •  KBI’s research service capacity for NASH associated diseases in cynomolgus monkeys

Speakers: